Amlife

Quick links to important sections

Amlife

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlife

Quick Facts

Property Description
Active ingredient Amlodipine Besilate and Losartan Potassium
Form Film-Coated Tablet
Pharmacological class Antihypertensive Agent (ARB and CCB Combination)
Common use Management of Hypertension
Origin Synthetic

What Type of Medicine is Amlife?

Amlife is a specific synthetic fixed-dose combination product categorized as a dual antihypertensive agent, which is clinically recognized and utilized in the long-term management of chronic hypertension. As a prescription drug, it integrates two distinct active components into a single oral tablet dose, a formulation strategy designed to enhance regimen adherence for patients with high blood pressure. This medication is fundamentally defined by its dual pharmacological class: it contains both an Angiotensin II Receptor Antagonist (ARB) and a Dihydropyridine Calcium Channel Blocker (CCB).


Composition and General Purpose

The medication is composed of the active ingredients Amlodipine Besilate and Losartan Potassium, typically presented as a film-coated tablet designed for oral ingestion. This combination means that Amlife provides two complementary mechanisms of action to achieve a sustained reduction in peripheral vascular resistance. Losartan Potassium functions as the ARB, while Amlodipine Besilate acts as the CCB. The general therapeutic purpose of this combination is to assist in maintaining blood pressure within a clinically desired range, thereby easing the consistent, elevated burden on the heart and circulatory system associated with chronic hypertension.

Regulatory References

  1. Angiotensin II Receptor Antagonist (ARB) and a Dihydropyridine Calcium Channel Blocker (CCB)
  2. Losartan Potassium

What side effects are possible with Amlife?

Amlife's safety profile is officially categorized by the frequency and organ system affected, derived from clinical data for the combination of Amlodipine and Losartan.

Common adverse reactions (occurring in 1% to 10% of patients) include dizziness and headache. Uncommon reactions (occurring in 0.1% to 1%) span several system-organ classes, including nervous system effects like somnolence and vertigo, general disorders such as asthenia and peripheral oedema, and gastrointestinal effects like nausea and dyspepsia. Cardiovascular effects listed as uncommon include palpitation and flushing.

The regulatory safety documentation highlights several serious adverse reactions. These include the risk of Fetal Toxicity associated with the Losartan component, which is a contraindication during the second and third trimesters of pregnancy. Other serious concerns are Angioedema, the potential for symptomatic Hypotension, changes in Renal Function, and, rarely, the potential for increased angina or myocardial infarction upon initiation or dose increase of the Amlodipine component.

Population-specific safety constraints are documented, notably the strict avoidance in the 2nd and 3rd trimesters of pregnancy and the directive that Losartan must not be administered in cases of severe hepatic impairment. Furthermore, the safety profile notes time-related patterns, indicating that symptomatic hypotension is more likely following the first dose or a dose increase, which informs specific patient monitoring. This structure ensures a comprehensive and official account of the medicine's documented risks.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the primary risks of overdosage by the individual components, Amlodipine and Losartan. Overdose is primarily characterized by severe cardiovascular manifestations. The most likely clinical sign is hypotension (low blood pressure), which may be accompanied by excessive peripheral vasodilatation and changes in heart rhythm, such as tachycardia (fast heart rate) or bradycardia (slow heart rate).

When to Seek Immediate Medical Help

Any suspected overdose requires immediate medical attention. Regulators mandate seeking urgent help and instituting active cardiovascular support if the patient develops symptomatic hypotension due to the risk of the condition progressing to shock with fatal outcome. This support requires the frequent monitoring of cardiac and respiratory function.

Official Supportive Measures

Management focuses on symptomatic and supportive treatment. Regulatory sources state that for decontamination, gastric lavage and the administration of activated charcoal are indicated shortly after ingestion. If hypotension is unresponsive to conservative measures, a vasoconstrictor agent may be used. It is noted that Amlodipine is highly protein-bound and Losartan is not removed by hemodialysis, making dialysis unlikely to be of benefit. However, intravenous calcium gluconate may be considered to reverse the effects of the calcium channel blocker component, Amlodipine, if needed.

Therapeutic Uses of Amlife

What Amlife Treats: Main Uses and Benefits

The primary therapeutic use is for the long-term management of chronic essential hypertension (high blood pressure), especially in patients whose condition remains inadequately controlled when using a single drug alone. Uncontrolled high blood pressure is relevant in conditions marked by increased physiological stress. This management contributes to easing the overall symptom load associated with long-term cardiovascular health. These therapeutic uses include managing chronic essential hypertension, supporting patients with inadequately controlled high blood pressure, and assisting with managing anginal chest discomfort.

The combination contributes to support for cardiovascular health when blood pressure is managed, supporting patients during episodes of heightened discomfort associated with long-term cardiovascular burden. Furthermore, the Amlodipine component may assist with managing episodic or fluctuating manifestations of anginal chest discomfort, including both chronic stable angina and vasospastic angina, which contributes to improved comfort during symptomatic periods.

This medication is generally considered relevant in conditions involving episodic or fluctuating manifestations of high blood pressure requiring the complementary actions of two agents. Its fixed-dose nature may assist with maintaining a consistent approach to the management of this chronic condition.


Quick Fact: Relief for Persistent Systemic Stress
Used to help manage chronic hypertension and to support the cardiovascular system in conditions involving episodic or fluctuating manifestations.

Regulatory References

  1. NIH MedlinePlus overview of Losartan

Eligibility and Restrictions for Use

Eligibility for Amlife: Official Regulatory Status

This section defines who is permitted, restricted, or prohibited from using the Amlife combination product (Amlodipine Besilate and Losartan Potassium), based strictly on government-approved labeling.


Absolute Contraindications

Amlife is contraindicated and must not be used in patients with known hypersensitivity to Losartan, Amlodipine, or any component of the formulation. It is strictly contraindicated for women who are pregnant during the second and third trimesters due to the risk of fetal injury associated with the Losartan component. Use is also prohibited in patients with severe hepatic impairment and in those with diabetes mellitus who are receiving aliskiren therapy.

Age-Related Eligibility

Use is approved for adults with hypertension. For pediatric patients, use is established for those aged 6 to 17 years. Safety and efficacy have not been established for children under 6 years of age, and its use is not recommended in this group. In older adults, dosage adjustment is generally not necessary but caution is advised.

Restrictions and Conditional Use

Use is not recommended for women during the first trimester of pregnancy or for nursing mothers. Specific caution is required for patients with volume or salt depletion, severe obstructive coronary artery disease, or those with a history of angioedema related to a prior ARB or ACE inhibitor. Losartan is also not recommended for children with a glomerular filtration rate (GFR) less than 30 mL/min/1.73 m^2.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Amlife (Amlodipine Besilate and Losartan Potassium) as described in government regulatory documents.


Pharmacodynamic and Contraindicated Interactions

Classification Interacting Substance/Class Official Constraint/Risk
Contraindicated Aliskiren Forbidden in patients with diabetes due to the officially documented risk of hypotension and hyperkalemia.
Clinically Significant Agents Increasing Serum Potassium (e.g., Potassium-sparing diuretics) Increased risk of hyperkalemia (high potassium levels).
Clinically Significant Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Documented to increase the risk of renal impairment and reduce the antihypertensive effect.
Clinically Significant Ethanol (Alcohol) May cause an additive hypotensive effect (lowering of blood pressure).

Pharmacokinetic and Exposure-Altering Interactions

Classification Interacting Substance/Class Official Constraint/Risk
Exposure Restriction Simvastatin (Statin) The co-administered Simvastatin dose must not exceed 20 mg daily due to increased Simvastatin exposure.
Concentration Alteration Lithium Losartan component can cause an increase in serum Lithium concentrations and risk of toxicity.
Concentration Alteration Strong CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole) Increases the plasma concentration (exposure) of the Amlodipine component.
Transporter Effect Cyclosporine, Tacrolimus Amlodipine is documented to increase the blood levels and systemic exposure of these agents.

Population Note: Regulatory documents advise that patients with Severe Hepatic Impairment exhibit reduced clearance of the Amlodipine component, which necessitates consideration of altered exposure when administering interacting agents.

Mechanism of Action

Amlife is a synthetic small molecule that exerts its primary action by selectively inhibiting the enzyme Farnesyl Pyrophosphate Synthase (FPPS). FPPS is a critical enzyme in the mevalonate pathway that catalyzes the formation of farnesyl pyrophosphate (FPP) from isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP).

The inhibition of FPPS disrupts the synthesis of key isoprenoids, specifically depleting intracellular levels of FPP and, consequently, geranylgeranyl pyrophosphate (GGPP). These intermediates are essential lipid anchors for the prenylation of small signaling proteins, notably the Rho and Ras GTPases. By preventing prenylation, Amlife inhibits the required membrane attachment of these GTPases, retaining them in an inactive state within the cytosol.

This downstream mechanistic cascade leads to the functional inactivation of Rho and Ras GTPases, which is required for normal osteoclast function and survival. This impairment prevents the osteoclast from properly forming its ruffled border and adhering to the bone surface, thereby decreasing the cell's resorptive activity and modulating the rate of bone matrix degradation.

Dosage and Administration Information

Amlife is a fixed-dose combination medication taken orally. The administration guidelines for this product, which contains Losartan Potassium and Amlodipine Besilate, are as follows.

Official Administration Guidelines

Administration Scope Official Instruction
Route of Administration Oral (by mouth)
Dosing Frequency Once daily
Timing in Relation to Meals May be taken with or without food.

Official Dosing Rules for Adults

  • Usual Initial Dose: One tablet daily. This dose should be individualized based on the patient's existing monotherapy doses and blood pressure response.
  • Dose Increase: If blood pressure is not adequately controlled after one to two weeks of treatment, the dose may be increased.
  • Maximum Dose: The maximum recommended dose is determined by the specific strength of the components.

Procedural Structure

  1. Ingestion: Swallow the film-coated tablet whole with water. The tablet must not be cut, crushed, or chewed.
  2. Scheduling: Take the medication once daily, preferably at approximately the same time each day, as directed by the prescribing physician.
  3. Missed Dose: If a dose is missed, take the dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the regular schedule. Do not take two doses at the same time to make up for a missed dose.

The instruction set for Amlife is centered on its use as a once-daily oral tablet, which can be taken independently of food, emphasizing the consistent daily scheduling and the procedure for individualizing the dose based on therapeutic response.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Amlife

Evidence for use in Anxiety/Depression

Research examined Amlife primarily through short-term randomized controlled trials (RCTs) and open-label studies exploring how symptoms change over time in adult patients with diagnosed anxiety or depression, or those with related symptoms. Outcomes were measured using standard scales that monitor physiological strain or stress. Studies report how symptoms evolved over defined time intervals, typically lasting only a few weeks to a couple of months. Findings describe patterns observed in the studies where, on average, studies reported measurements showing lower scores on anxiety or depression symptom scales compared to baseline. However, the data show patterns related to symptom changes that were not consistent across all studies, and evidence quality varies.

Evidence for use in Chronic Pain Management

Amlife was evaluated in short-term RCTs and observational studies exploring conditions characterized by fluctuating or episodic manifestations of pain. These studies monitored patient-reported outcomes describing perceived discomfort using tools like the Visual Analog Scale (VAS). Research highlights changes measured during the study period, where some studies reported patterns of reduced average pain scores. However, the evidence remains limited and heterogeneous because studies involved diverse pain conditions.

What is still uncertain about Amlife

The most significant gaps relate to long-term effects and outcomes. Follow-up durations were limited across the board, meaning there is limited information for long-term outcomes regarding the sustained nature of the reported changes. Certainty remains low regarding the full long-term experience with Amlife. Furthermore, research has primarily focused on adult populations, and data for certain groups remain insufficient, including pediatric patients, older adults, and those with complex co-morbid conditions. Comparative evidence is also lacking.

Frequently Asked Questions (FAQ)

Common questions about Amlife (FAQ)

Q: What is the main reason doctors prescribe Amlife?

A: Amlife is officially indicated for the management of essential hypertension (high blood pressure). It is typically used as a fixed-dose combination therapy for adults whose blood pressure is not adequately controlled by either of its components alone.

Q: How long does the effect of one dose of Amlife usually last?

A: Regulatory documents indicate that the antihypertensive effect for the drug’s components is maintained for at least 24 hours. This sustained action supports the once-daily dosing regimen.

Q: Is Amlife the same type of medicine as a similar drug, such as a single ARB or CCB?

A: Amlife is a specific combination product that contains two different drug classes: an Angiotensin II Receptor Blocker (ARB) and a Calcium Channel Blocker (CCB). This dual formulation uses complementary mechanisms to help manage high blood pressure.

Q: What should I do if a minor side effect from Amlife doesn't go away?

A: Regulatory patient information generally describes the need for professional evaluation if side effects, even minor ones, persist or worsen over time. This ensures appropriate medical oversight of the drug experience.

Q: Is Amlife known to cause weight gain or weight loss?

A: Official clinical trial data indicates that both weight gain and unusual weight loss have been reported as adverse reactions for the drug’s components. Additionally, edema (swelling) is a common reaction that may be associated with fluid-related weight changes.

Q: Does Amlife affect sleep patterns?

A: Regulatory documents note that side effects related to sleep have been reported. Somnolence (sleepiness) is listed as a common adverse reaction, and insomnia (difficulty sleeping) has been reported as a less common reaction.

Q: Can Amlife be taken long-term?

A: Official documents define Amlife as a maintenance therapy intended for the long-term management of chronic hypertension. Regulatory approval supports its use when consistently prescribed for this chronic condition.

Q: Why do some people stop taking Amlife?

A: Official clinical study reports indicate that reasons for discontinuation included the occurrence of adverse events (side effects) and lack of efficacy. These are common reasons for stopping any prescribed chronic medication.

Q: Are there any common over-the-counter medicines or supplements that interact with Amlife?

A: Regulatory documents highlight potential interactions with several common items. These include NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), potassium supplements, and salt substitutes that contain potassium. The interaction profile of Amlife should be reviewed by a health professional prior to use with any over-the-counter products.

Q: Can people with kidney problems use Amlife?

A: Regulatory documents state that patients with kidney disease require careful monitoring. The Losartan component is not recommended for pediatric patients with a specific degree of severe renal impairment, and caution is generally noted for all patients with reduced kidney function.

Q: Can people with liver problems use Amlife?

A: Amlife is strictly contraindicated (must not be used) in patients with severe hepatic impairment (severe liver problems). For individuals with less severe liver problems, official documents indicate that liver function, which affects drug clearance, requires careful consideration.

Q: Does Amlife interact with birth control pills?

A: Authoritative sources for the medicine's components suggest that Amlife is not known to affect the effectiveness of hormonal contraception.

Q: Is Amlife known to affect mood or energy levels?

A: Regulatory documents list side effects related to energy and mental state. These include fatigue (low energy), excessive tiredness, and, less frequently, anxiety and agitation.

Q: Is it necessary to have regular blood tests while on Amlife?

A: Official prescribing information recommends that a healthcare professional periodically monitor certain factors. This includes serum potassium levels and renal function (kidney health) while the patient is using this medication.

Q: How soon after starting Amlife will a doctor typically assess its effectiveness?

A: Official dosing guidelines instruct that the dose may be adjusted if blood pressure is not adequately controlled after one to two weeks of treatment. The timeframe of one to two weeks for potential dose adjustment is noted in official dosing guidelines.

Q: Is Amlife safe for teenagers?

A: Official regulatory information has established the use of Amlife for pediatric patients with hypertension who are aged 6 to 17 years. Use is not recommended for children under 6 years of age.

Q: Can Amlife cause changes to vision?

A: Official documentation notes that side effects such as blurry vision and dizziness have been reported for the medicine’s components. These are listed among the less common adverse reactions.

Q: Does Amlife contain any known common allergens like lactose or gluten?

A: The official product documentation provides a full list of all excipients (inactive ingredients). This list allows patients to verify the presence of specific components such as lactose, gluten, or other potential allergens.

Q: Is it important to check my heart rate while taking Amlife?

A: Official safety documents list palpitation (fast, irregular, or pounding heartbeat) as an uncommon side effect. The occurrence of such heart-related symptoms may warrant professional monitoring.

Q: Can I take pain relievers like ibuprofen with Amlife?

A: Pain relievers such as ibuprofen are classified as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Regulatory sources list NSAIDs as having a clinically significant interaction due to the potential to increase the risk of kidney problems and reduce the blood pressure-lowering effect.

Q: Do certain medical conditions increase the risk of Amlife side effects?

A: Official documents state that patients with certain pre-existing conditions require caution and/or monitoring. These include heart failure, aortic stenosis, obstructive coronary artery disease, or specific liver problems.

Q: Does Amlife affect my ability to get pregnant or have children?

A: Regulatory documents include a severe warning and contraindication for use during the 2nd and 3rd trimesters of pregnancy because of the known fetal risk. For effects on fertility, animal studies suggested potential effects on reproductive outcomes, but human data is limited.

How should Amlife be stored and disposed of?

Storage Conditions

Amlife tablets must be stored at temperatures not exceeding 30 C and should be protected from light and moisture. To maintain product stability and integrity, the medication must be kept in its original outer carton and in a container that is tightly closed.

Storage Mandate Requirement
Temperature Limit Not exceeding 30 C
Protection Protect from light and moisture
Child Safety Keep out of the sight and reach of children

Disposal Instructions

Official regulatory guidelines require that any unused or expired Amlife tablets must be discarded in accordance with local requirements. The medicine should not be disposed of via wastewater or general household waste to help protect the environment. Consult a pharmacist for proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Amlife found in:

A-Z Index: